載入...
Emerging drugs for treatment of focal segmental glomerulosclerosis
BACKGROUND: Glomerulosclerosis represents the final stage of glomerular injury during the course of kidney disease and can represent a primary disturbance in disorders like focal segmental glomerulosclerosis or a secondary response to tubulointerstitial disease. Overall, primary focal glomeruloscler...
Na minha lista:
| 發表在: | Expert Opin Emerg Drugs |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7508791/ https://ncbi.nlm.nih.gov/pubmed/32729368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14728214.2020.1803276 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|